Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles K. Gayer currently holds 902,583 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles K. Gayer has been a net buyer of BCRX stock. They have purchased $164.1K and sold $66.5K worth of shares.
Charles K. Gayer's most recent insider trade was on Dec 22, 2025, when they sold 10,091 shares at $5.04 per share.
Charles K. Gayer serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 15 insider transactions totaling $230.6K over their tenure at the company.
Charles K. Gayer holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Charles K. Gayer has shown a buying trading pattern, with $164.1K in total purchases and $66.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles K. Gayer was on Dec 22, 2025, when they sold $275.5K worth of BCRX shares. This transaction involved 50,000 shares at $5.51 per share.
Charles K. Gayer currently owns 902,583 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles K. Gayer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles K. Gayer has 15 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Charles K. Gayer and 40,000+ other insiders.